Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-1.30 Insider Own8.17% Shs Outstand95.34M Perf Week11.68%
Market Cap145.87M Forward P/E- EPS next Y-1.19 Insider Trans0.00% Shs Float87.55M Perf Month-15.47%
Income-138.96M PEG- EPS next Q-0.29 Inst Own45.91% Short Float / Ratio9.62% / 3.55 Perf Quarter-16.39%
Sales2.63M P/S55.46 EPS this Y4.67% Inst Trans-4.95% Short Interest8.42M Perf Half Y-25.73%
Book/sh0.79 P/B1.92 EPS next Y5.57% ROA-70.82% Target Price10.40 Perf Year-47.96%
Cash/sh0.89 P/C1.71 EPS next 5Y- ROE-131.82% 52W Range1.14 - 4.05 Perf YTD-55.65%
Dividend- P/FCF- EPS past 5Y1.04% ROI-85.11% 52W High-62.22% Beta0.43
Dividend %- Quick Ratio3.88 Sales past 5Y247.46% Gross Margin-525.70% 52W Low34.29% ATR0.14
Employees233 Current Ratio3.88 Sales Q/Q-17.20% Oper. Margin-5652.55% RSI (14)49.44 Volatility10.00% 8.89%
OptionableYes Debt/Eq1.29 EPS Q/Q3.70% Profit Margin-5283.73% Rel Volume0.80 Prev Close1.30
ShortableYes LT Debt/Eq1.21 EarningsNov 08 AMC Payout- Avg Volume2.37M Price1.53
Recom1.00 SMA203.59% SMA50-14.16% SMA200-26.55% Volume1,886,420 Change17.69%
Date Action Analyst Rating Change Price Target Change
Mar-31-23Initiated Evercore ISI Outperform
Mar-28-23Initiated B. Riley Securities Buy $8
Oct-31-22Initiated Piper Sandler Overweight $6
Aug-22-22Downgrade Goldman Neutral → Sell $2
Dec-15-21Resumed Goldman Neutral $15
Oct-15-21Resumed BTIG Research Buy $20
Jan-20-21Downgrade Robert W. Baird Outperform → Underperform $8
Jul-26-19Initiated Robert W. Baird Outperform $17
Mar-15-19Initiated Raymond James Outperform
Mar-07-19Initiated H.C. Wainwright Buy $17
Nov-20-23 07:00AM
Nov-08-23 06:43PM
Nov-07-23 04:30PM
Oct-12-23 05:00PM
07:10AM Loading…
Oct-11-23 07:10AM
Oct-10-23 07:00AM
Oct-04-23 04:05PM
Sep-27-23 04:01PM
Sep-13-23 04:30PM
Sep-05-23 07:00AM
Aug-16-23 04:30PM
Aug-15-23 07:00AM
Aug-09-23 04:05PM
Aug-07-23 07:00AM
07:00AM Loading…
Jul-17-23 07:00AM
Jul-04-23 06:55AM
Jun-13-23 07:00AM
Jun-08-23 07:00AM
Jun-01-23 04:30PM
May-24-23 05:00PM
May-16-23 06:05AM
May-11-23 04:05PM
May-03-23 07:00AM
Apr-21-23 06:05AM
Apr-17-23 07:01AM
Apr-10-23 07:00AM
Apr-04-23 06:30PM
Mar-15-23 07:00AM
07:18AM Loading…
Mar-11-23 07:18AM
Mar-09-23 04:05PM
Mar-02-23 07:00AM
Feb-27-23 04:06PM
Feb-14-23 07:00AM
Jan-25-23 05:34AM
Jan-24-23 07:00AM
Jan-18-23 05:30PM
Dec-15-22 04:31PM
Dec-13-22 07:00AM
Dec-05-22 08:30AM
Nov-21-22 07:30AM
Nov-17-22 07:00AM
Nov-10-22 09:00AM
Nov-03-22 06:04PM
Oct-25-22 07:01AM
Oct-19-22 09:43AM
Oct-17-22 07:00AM
Sep-20-22 07:00AM
Sep-12-22 07:00AM
Sep-01-22 04:05PM
Aug-17-22 07:00AM
Aug-15-22 04:05PM
Aug-10-22 04:05PM
Aug-04-22 04:05PM
Aug-01-22 06:38AM
Jul-26-22 07:00AM
Jul-21-22 04:06PM
Jul-05-22 08:00AM
Jun-10-22 08:00AM
Jun-08-22 04:05PM
Jun-02-22 08:00AM
May-31-22 08:00AM
May-17-22 05:00PM
May-09-22 08:32AM
May-06-22 07:30PM
May-05-22 04:05PM
May-02-22 07:00AM
Apr-27-22 04:05PM
Apr-12-22 04:35PM
Mar-30-22 07:00AM
Mar-17-22 12:14PM
Mar-10-22 04:05PM
Mar-08-22 05:15PM
Feb-24-22 07:00AM
Feb-22-22 05:34AM
Feb-08-22 04:05PM
Feb-07-22 10:45AM
Jan-25-22 04:05PM
Jan-13-22 07:00AM
Jan-12-22 06:15AM
Jan-05-22 05:14PM
Jan-04-22 07:00AM
Dec-30-21 07:00AM
Dec-17-21 07:00AM
Dec-13-21 04:05PM
Dec-09-21 08:41AM
Dec-06-21 07:00AM
Nov-29-21 07:00AM
Nov-23-21 04:05PM
Nov-10-21 07:00AM
Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Economides VassilikiSee RemarksMay 23Buy1.9012,00022,829214,058May 24 05:24 PM